There is a great need for sensitive, precise, and easily accessible analytical detection techniques for protein sequencing.

Biologics Quality Control: The Growing Need for Accessible Proteomics

The emergence of mRNA vaccines and cell and gene therapies has pushed innovation in analytical methods.

Emerging Therapies Drive Analytical Advancements

Effective analytics will eliminate failures, deviations, and non-conformances.

 Analyzing Exabytes

Topic

Felicity Thomas is the former Associate Editorial Director of Pharmaceutical Technology, Pharmaceutical Technology Europe, BioPharm International.

Articles

Assays can provide a useful tool in determining the potential toxicity of drugs throughout the development cycle.


Keeping Toxicity to a Minimum

Metrology has the potential to not only prevent harm to patients but also to support innovative therapeutic options.


Going with the Flow

Outsourcing stability testing to full-service providers can offer comprehensive benefits to bio/pharma companies.


The Benefits of Outsourcing Stability Testing

Robert Shaw is principal scientist statistics, Oral Product Development, Operations, AstraZeneca Pharmaceuticals, Macclesfield, Cheshire, United Kingdom, SK102NA, Robert.Shaw@astrazeneca.com. 

Marie South is associate director, Discovery Sciences Statistics, AstraZeneca Pharmaceuticals, Alderley Park, Cheshire, United Kingdom, SK104TG (until 2015).

The authors present a simple-to-use Microsoft Excel-based statistical tool that uses cumulative sum techniques to aid retrospective understanding of data trends.

Implementation of Autocorners Algorithm for Retrospective Process Monitoring

Eurofins DiscoverX partners with VelaLabs to enable VelaLabs to perform highly reproducible potency lot release assays under GLP/GMP conditions.

Eurofins DiscoverX Grants Bioassay Certification to VelaLabs

Bio-chromatography development and manufacturing company, BIA Separations, has signed a license agreement with the University of Zagreb to commercialize a novel elution method for virus and viral vector purification.


BIA Separations Signs License Agreement with University of Zagreb

An evaluation by USP indicates bovine heparin is a potential alternative to porcine heparin.

Bovine Heparin Meets Acceptable Impurity Levels

Synthetic biology can help researchers circumvent the challenges of traditional methods of antibody generation.

Antibody Development Made Easier with Synthetic Biology

Cynthia A. Challener is a contributing editor to Pharmaceutical Technology.

Researching excipient grades and sources, as well as screening suppliers and materials, form the basis of programs to mitigate risk.

The Search for Transparency in Excipient Sourcing

Analytical solutions are improving for raw material testing, drug product release process development, and more.

Analytics

Biologics Quality Control: The Growing Need for Accessible Proteomics

Emerging Therapies Drive Analytical Advancements

Analyzing Exabytes